Viscosupplementation is an injectable procedure used to treat knee osteoarthritis (OA) by injecting a gel-like substance called hyaluronic acid (HA) directly into the knee joint. Hyaluronic acid is a natural component of healthy joint fluid (synovial fluid), where it acts as a lubricant and shock absorber, facilitating smooth movement and protecting cartilage. In individuals with knee OA, the quality and quantity of natural hyaluronic acid in the synovial fluid diminish, leading to increased friction, pain, and stiffness.

The primary goal of viscosupplementation is to replenish the depleted hyaluronic acid, thereby restoring the joint’s natural lubrication and cushioning properties. This can help to reduce pain, improve joint function, and enhance mobility for patients who have not found sufficient relief from other conservative treatments like pain relievers, physical therapy, or corticosteroid injections. The treatment is typically administered as a series of injections over several weeks, though single-injection formulations are also available.

While viscosupplementation is generally considered safe, potential side effects can include temporary pain, swelling, or warmth at the injection site. More serious, though rare, complications can include allergic reactions or infection. The effectiveness of viscosupplementation can vary among individuals, with some experiencing significant pain relief and improved function for several months, while others may find limited benefit. It is important for patients to discuss the potential benefits and risks with their healthcare provider to determine if viscosupplementation is an appropriate treatment option for their specific condition.